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Abstract
Background: We hypothesize that depression in type 2 diabetes might be
associated with poor glycemic control, in part due to suboptimal self-care. We
tested this hypothesis by examining the associations of depression with clinical
and laboratory findings in a multicenter survey of Chinese type 2 diabetic
patients.
Method: 2538 patients aged 18–75 years attending hospital-based clinics in
four cities in China underwent detailed clinical-psychological-behavioral
assessment during a 12-month period between 2011 and 2012. Depression was
diagnosed if Patient Health Questionnaire-9 (PHQ-9) score ≥10. Diabetes
self-care and medication adherence were assessed using the Summary of Dia-
betes Self-care Activities and the 4-item Morisky medication adherence scale
respectively.
Results: In this cross-sectional study (mean age: 56.4 ± 10.5[SD] years, 53%
men), 6.1% (n = 155) had depression. After controlling for study sites, patients
with depressionhadhigherHbA1c (7.9 ± 2.0 vs. 7.7 ± 2.0%,P = 0.008) andwere
less likely to achieve HbA1c goal of <7.0% (36.2% vs 45.6%, P = 0.004) than
thosewithout depression. Theyweremore likely to report hypoglycemia and to
have fewer days of being adherent to their recommended diet, exercise,
foot care and medication. In logistic regression, apart from young age,
poor education, long disease duration, tobacco use, high body mass index,
use of insulin, depression was independently associated with failure to
Significant findings of the study: The present study found depression was closely associated with poor glycemic
control and hypoglycemia accompanied by poor treatment adherence in Chinese patients with type 2 diabetes.
What this study adds: The findings extend the knowledge on the relationship between depression and diabetes in
Chinese, which highlights the need for a holistic approach to manage depression which might improve treatment
adherence and glycemic control.
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attain HbA1c target (Odds Ratio [OR] = 1.56, 95%CI:1.05–2.32, P = 0.028).
The association between depression and glycemic control became non-
significant after inclusion of adherence to diet, exercise and medication
(OR = 1.48, 95% CI 0.99–2.21, P = 0.058).
Conclusion: Depression in type 2 diabetes was closely associated with hyper-
glycemia and hypoglycemia, which might be partly mediated through poor
treatment adherence.
Keywords: depression, hyperglycemia, hypoglycemia, treatment adherence,
type 2 diabetes.
Introduction
The growing burden of type 2 diabetes and associated
premature cardiovascular morbidity and mortality is
universal and poses major threats to countries in both
health and economic terms.1 Diabetes complications and
treatment-associated side effects can have negative
effects on both physical and mental health.2 Further-
more, demands for adjustments and adaptation to life-
style and self-care regimens can cause emotional stress,
which may impair patients’ motivation to adhere to dia-
betes self-management.3
Type 2 diabetes is associated with increased risk of
depression4 and their co-occurrence can further compro-
mise the control of cardiometabolic risk factors with
increased risks of complications and functional impair-
ment.5,6 Herein, multiple factors including but not
limited to disease duration, use of anti-diabetic drugs,
adherence to medications and lifestyle changes might
influence glycemic control although their inter-
relationships have not been well defined. Against this
background, we hypothesize that depression might
impair an individual’s motivation and ability to comply
with complex self-care measures and medications, result-
ing in fluctuation of glycemic control. In a multicenter
cross-sectional study (Depression in Chinese Patients
with Type 2 Diabetes, DD2) involving four large cities in
China, we tested this hypothesis by examining the asso-
ciations of depression with glycemic control and their
possible mediating factors in type 2 diabetic patients
receiving ambulatory care with detailed documentations
of clinical, laboratory, emotional and behavioral
measures.
Methods
Patients and setting
The study enrolled patients with type 2 diabetes from six
tertiary hospitals in four major cities in China: Hong
Kong (Prince of Wales Hospital), Beijing (Peking Union
Hospital, Beijing People’s Hospital and China-Japan
Friendship Hospital), Shanghai (Shanghai Sixth Peoples’
Hospital) and Guangzhou (The Third Affiliated Hospi-
tal of Sun Yat-Sen University). Between July 2010 and
July 2011, Chinese patients with type 2 diabetes aged
between 25 and 75 years who underwent comprehensive
assessments at these six centers were invited to partici-
pate in the study. Referral sources included specialty
out-patient clinics and community out-patient clinics.
Patients were excluded if they had type 1 diabetes (pre-
sentation with diabetic ketoacidosis or continuous
requirement of insulin within one year of diagnosis), dis-
abling disease or reduced life expectancy (e.g. severe
heart failure, severe respiratory disease, or late stages of
cancer) or difficulty in communication. All participants
gave written informed consent and the study was
approved by the local institutional ethics boards.
Clinical assessment
All participants underwent comprehensive examination
based on the procedures set out by the Joint Asia Dia-
betes Evaluation (JADE) program. The latter is a web-
based portal containing templates for comprehensive
assessment, risk engines, personalized report and deci-
sion support.7–10 Sociodemographic details, family
history of diabetes and mental illness, cardiovascular-
metabolic indices, complications and comorbidities, life-
style factors, self-care and use of medications were
documented. Hypoglycemia was assessed by asking
patients if they had experienced symptoms of hypogly-
cemia during the past 3 months. Blood pressures (BP)
and anthropometric measurements were collected.
Diabetic retinopathy was examined by fundoscopy or
retinal photography. Peripheral sensory neuropathy was
assessed by graduated tuning fork and monofilament.
Sensory neuropathy was defined by two of three criteria:
abnormal sensation in lower extremities, reduced sensa-
tion on monofilament or tuning fork testing. Cardiovas-
cular disease was defined by a history of coronary heart
disease, stroke or peripheral vascular disease; the latter
defined as non-traumatic lower extremity amputation or
ankle:brachial index (ABI) less than 0.9.
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Urine and blood samples were collected after at least
8 h of overnight fasting for plasma glucose, glycated
hemoglobin (HbA1c), total cholesterol, low density-
lipoprotein-cholesterol (LDL-C), high density-
lipoprotein-cholesterol (HDL-C), triglyceride, renal
function test and random spot urinary albumin-to-
creatinine ratio (ACR). Hypertension was defined as
systolic BP ≥130 mmHg and/or diastolic BP ≥80 mmHg
and/or concurrent use of anti-hypertensive drugs. Dys-
lipidaemia was defined as LDL-C ≥2.6 mmol/L, HDL-C
<1.0 mmol/L, triglyceride ≥2.3 mmol/L and/or concur-
rent use of lipid regulating drugs. Estimated glomerular
filtration rate (eGFR) as expressed in mL/min per
1.73 m2 was calculated using the abbreviated Modifica-
tion of Diet in Renal Disease (MDRD) equa-
tion: eGFR = 186×[SCR×0.011]–1.154×[age]–0.203×[0.742 if
female], where SCR was serum creatinine in μmol/L.11
Chronic kidney disease (CKD) was defined as eGFR
<60 mL/min per 1.73 m2 while end-stage renal disease
was defined as eGFR <15 mL/min per 1.73m,2 require-
ment of renal transplant or dialysis. Microalbuminuria
was defined as urinary ACR ≥2.5–25.0 mg/mmol in men
and ≥3.5–25 mg/mmol in women, while macroalbuminu-
ria was defined as urinary ACR ≥25 mg/mmol.
Mental and behavioral measurement
Participants were requested to complete validated self-
administered questionnaires including the Patient Health
Questionnaire-9 (PHQ-9),12 the Summary of Diabetes
Self-Care Activities (SDSCA),13 and the 4-item Morisky
scale for medication adherence.14 The PHQ-9 is a multi-
purpose instrument for screening, diagnosing, monitor-
ing and measuring the severity of depression.12 It consists
of nine questions derived from the DSM-IV diagnostic
criteria for major depression. In our previous validation
study in Hong Kong Chinese type 2 diabetic patients, the
optimal cutoff score to detect depression was 7 with
82.6% sensitivity and 73.7% specificity.15 For comparison
purpose, we used the widely accepted cutoff point of 10
(88% sensitivity and 88% specificity in the original vali-
dation study with most participants being Caucasians) to
detect probable depression in our study.12,16
The SDSCA is used to assess the frequencies of dia-
betes self-care behaviors including diet, exercise, self-
monitoring of blood glucose (SMBG), foot care,
medication adherence and smoking in the previous 7
days.13 According to the author, the two items on
general diet and another two items on specific dietary
recommendations: (i) eating five or more servings of
fruits and vegetables; and (ii) eating high-fat foods
should be analyzed separately.13 In addition, we
included the following question to test knowledge on
corrective action for hypoglycemia: “how many days in
the previous week did you bring candy with you
according to recommendation”. In the SCSDA, there
are two items on the use of medications. One relates to
the use of oral anti-diabetic drugs, which does not need
to be answered by patients treated with lifestyle modi-
fication or insulin only. The other relates to insulin use,
which does not need to be answered by patients not
treated with insulin. However, many patients errone-
ously answered these items, probably due to oversight
of the remarks. Thus we excluded these two items when
we calculated the mean score for each item related to
self-care behavior.
The Morisky medication adherence scale consists of
four “yes/no” questions, scored 0 and 1, respectively.14
The total score ranges from 0 to 4, with “4” indicating
high adherence; “2–3”, intermediate adherence and
“0–1” low adherence to medication use. The medication
adherence score has been shown to have satisfactory
internal consistency with concurrent and predictive
validity with 81% sensitivity and 44% specificity for
detection of non-adherence to medication.14
Statistical analysis
All data were analyzed using the Statistical Package for
Social Science software (SPSS, Version 20.0, IBM). For
descriptive analysis, continuous variables were expressed
as mean ± standard deviation (SD), mean ± standard
error (SE), or median (inter-quartile range, IQR), and
categorical variables were expressed in number (percent-
age). Between-group comparisons were analyzed by χ2
square test, Student’s t-test, analysis of covariates
(ANCOVA) or logistic regression with adjustment for
study sites as appropriate.
We examined the associations of depression with self-
care behavior, medication adherence and glycemic
control using multivariate logistic regression. We con-
structed three models sequentially to identify indepen-
dent factors associated with failure to attain HbA1c target
of <7.0%. The covariables in Model 1 included probable
major depression plus important demographic charac-
teristics regardless of their significance in the univariate
analysis. These included study sites, age, gender, disease
duration, education level, and current use of tobacco.
Model 2 contained clinical characteristics with signifi-
cant difference (P < 0.1) between patients with and
without depression, in addition to variables from Model
1. Model 3 included significantly different self-care
behaviors and medication adherence as well as variables
from Model 2. We also explored the independent asso-
ciations of depression with self-reported hypoglycemia in
logistic regression after adjustment for known risk
factors for hypoglycemia including age, gender, disease
Depression in Chinese with type 2 diabetes Y. ZHANG et al.
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duration, education, regular alcohol use, HbA1c, diabetic
complications (eGFR, retinopathy, cardiovascular
disease, sensory neuropathy), use of insulin and sulpho-
nylurea, and treatment adherence (diet, exercise, and
medication adherence score).17 A P-value less than 0.05
(two-sided) was considered significant.
Results
After excluding 27 patients with incomplete data, 2538
Chinese patients with type 2 diabetes from Hong Kong
(n = 586), Shanghai (n = 463), Guangzhou (n = 464) and
Beijing (n = 1035) were included in the analysis. The
mean age of the participants was 56.4 ± 10.5 years, 53%
were male (n = 1346), and median diabetes duration was
6.0 (IQR: 2.0–10.0) years. The mean PHQ-9 score was
2.9 ± 3.8 (Table 1). Using the pre-specified cutoff value
of ≥10, 6.1% (n = 155) were considered to have depres-
sion with 8.9% (n = 52) in HongKong and 5.3% (n = 103)
averaged across other China sites. Among those with
probable major depression, less than one fifth (16.9%)
were taking psychotropic medications.
After controlling for study sites, patients with de-
pression had higher HbA1c (7.9 ± 2.0 vs. 7.7 ± 2.0%,
P = 0.008) and were less likely to achieve HbA1c goal of
<7.0% (36.2% vs 45.6%, P = 0.004). Patients with depres-
sion were more likely to report hypoglycemia during the
previous 3 months than those without depression (37.9%
vs 18.1%, P < 0.001), despite comparable use of sulpho-
nylurea and insulin. Depression was associated with 1.7–
2.0-fold higher prevalence of coronary heart disease and
sensory neuropathy despite similar blood pressures, body
mass index, blood lipids and renal function between those
with or without depression. Fewer subjects with depres-
sion reported high medication adherence score (which
indicated high medication adherence) than the non-
depressed group (38.7% vs 60.3%, P < 0.001) (Table 1).
This was accompanied by fewer days perweek of frequent
exercises, adherence to recommended diet regimen and
foot care, basedon the SDSCAquestionnaire in the group
with depression (Table 2).
Stepwise logistic regression showed that depression
was an independent factor for failure to attain HbA1c
target to <7.0%, in addition to young age, long disease
duration, low education level, smoking, higher body
mass index, and use of insulin (Table 3, Model 1 and 2).
However, the effect of depression became non-significant
after adding self-care behavior (diet, exercise) and medi-
cation adherence to the model (Table 3, Model 3). After
adjustment for sites, age, gender, disease duration, edu-
cation, history of retinopathy, sensory neuropathy, and
cardiovascular disease, HbA1c, eGFR, medication adher-
ence score, adherence to diet, exercise, use of insulin and
sulphonylurea, depression remained independently asso-
ciated with hypoglycemia (Table 4).
Discussion
In this study comprising more than 2500 patients with
type 2 diabetes recruited from six hospitals in four met-
ropolitan cities in China, over 6% had depression based
on a validated questionnaire, but less than one fifth of
these patients were treated with psychotropic medica-
tions. Patients with high PHQ-9 score were more likely to
have poor glycemic control and hypoglycemia, which
were associated with poor self-care and medication non-
adherence. Given the possibility of under diagnosis of
this silent condition, together with the high prevalence of
diabetes in China18 and the additive effects of these two
comorbid conditions on mortality and morbidity,19 these
data have important public health implications.
Prevalence of depression in type 2 diabetes
In a multicentre Translating Research Into Action for
Diabetes (TRIAD) study including over 8700 adults with
diabetes, predominantly Caucasians recruited from dif-
ferent managed care settings in US, 18% had major
depression based on a cutoff score of 10 using the PHQ-
8.20 In a previous analysis involving a subset of patients
in Hong Kong, we have validated the PHQ-9 in diagnos-
ing depression using interview by psychiatrists as gold
reference with a lower cutoff point of ≥7.15 In this multi-
center analysis, to allow for comparisons with literature,
we used a cutoff score of ≥10, which identified 6.1% of
subjects as having probable major depression. However,
if we adopt a cut-off value of seven which fits Chinese
samples,15 the prevalence of probable depression
increased to 13.0% (18.1% in Hong Kong and 11.5% in
other China sites), which was higher than that in the
general population21 and was quite close to data reports
from other countries.20
Some researchers suggested that the lower prevalence
of depression in Chinese compared to the Western popu-
lation might be in part due to cultural differences in the
depressive symptom expression.22–24 For instance, social
stigma associated with depression and the tendency to
somatize depressive symptoms may contribute to its
under-diagnosis in Chinese population.23,25 Traditional
Chinese culture encourages withstanding of hardship,
patience and forbearance as well as maintaining social
and family harmony through interdependence. These
cultural values may contribute to tolerance for emotional
burden and/or under-reporting of depression.23 In
support of this notion, we found that three items of the
PHQ-9 (sleep, energy, appetite) contributed significantly
Y. ZHANG et al. Depression in Chinese with type 2 diabetes
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Table 1 Comparison of demographic and clinical characteristics of participants with or without probable major depression (PHQ-9 score ≥10)
Total PHQ-9 < 10 PHQ-9 ≥ 10 P-value Adjusted P*
Number 2538 2383 (93.9) 155 (6.1) –
PHQ-9 score 2.9 ± 3.8 2.1 ± 2.4 14.0 ± 4.1 <0.001 <0.001
Age (years) 56.4 ± 10.5 56.5 ± 10.5 55.4 ± 10.7 0.211 0.165
Men 1346 (53.0) 1267 (53.2) 79 (51.0) 0.595 0.250
Duration of diabetes 6.0 (2.0, 10.0) 5.5 (2.0, 10.0) 6.0 (2.0, 11.0) 0.268 0.342
Education 0.370 0.290
<6 years 414 (16.3) 389 (16.3) 25 (16.1)
6–11 years 775 (30.5) 720 (30.2) 55 (35.5)
>11 years 1349 (53.2) 1274 (53.4) 75 (48.4)
Current smoker 416 (16.4) 385 (16.2) 31 (20.1) 0.198 0.332
Not in active employment 1505 (59.3) 1412 (59.4) 93 (60.0) 0.877 0.233
Family history of diabetes 1285 (50.6) 1202 (50.4) 83 (53.5) 0.453 0.594
Family history of mental illness 103 (4.2) 89 (3.8) 14 (9.7) 0.001 0.017
Metabolic control
Body mass index (kg/m2) 25.4 ± 3.7 25.4 ± 3.7 25.9 ± 4.3 0.09 0.151
Waist circumference, men (cm) 91.7 ± 9.6 91.5 ± 9.5 93.4 ± 10.2 0.086 0.086
Waist circumference, women (cm) 86.7 ± 10.0 86.6 ± 9.9 88.0 ± 10.9 0.235 0.123
Systolic BP (mmHg) 130 ± 16 130 ± 16 128 ± 18 0.214 0.857
Diastolic BP (mmHg) 78 ± 10 78 ± 10 78 ± 10 0.621 0.714
HbA1c (%) 7.7 ± 2.0 7.7 ± 2.0 7.9 ± 2.0 0.275 0.008
Total Cholesterol (mmol/L) 4.72 ± 1.13 4.72 ± 1.14 4.64 ± 1.08 0.352 0.877
HDL-C(mmol/L) 1.23 ± 0.33 1.23 ± 0.33 1.25 ± 0.33 0.427 0.954
LDL-C (mmol/L) 2.69 ± 0.84 2.69 ± 0.83 2.60 ± 0.95 0.197 0.969
Triglyceride (mmol/L) 1.40 (0.99, 2.08) 1.40 (1.00, 2.07) 1.42 (0.97, 2.19) 0.879 0.084
eGFR(mL/min/1.73m2) 121 ± 32 121 ± 32 120 ± 36 0.831 0.741
Urinary ACR (mg/mmo/L) 1.14 (0.58, 2.80) 1.14 (0.57, 2.80) 1.17 (0.59, 2.78) 0.896 0.841
Hypertension 1958 (78.5) 1839 (78.5) 119 (78.8) 0.926 0.753
Dyslipidemia 2253 (91.3) 2116 (91.4) 137 (89.0) 0.290 0.366
Self-reported hypoglycemia in previous 3 months 484 (19.3) 426 (18.1) 58 (37.9) <0.001 <0.001
Complications
Coronary heart disease 210 (8.3) 189 (7.9) 21 (13.5) 0.015 0.006
Stroke 92 (3.6) 87 (3.7) 5 (3.2) 0.784 0.798
Sensory neuropathy 333 (13.2) 296 (12.5) 37 (24.5) <0.001 <0.001
Retinopathy 301 (11.9) 284 (12.0) 17 (11.1) 0.743 0.368
Peripheral vascular disease 380 (15.9) 357 (15.8) 23 (16.4) 0.464 0.908
Chronic kidney disease 58 (2.4) 54 (2.4) 4 (2.6) 0.843 0.632
Microalbuminuria 393 (18.7) 369 (18.9) 24 (16.9) 0.565 0.582
Macroalbuminuria 120 (5.7) 109 (5.6) 11 (7.7) 0.283 0.267
End-stage renal disease 10 (0.4) 8 (0.3) 2 (1.3) 0.088 0.141
Medications and adherence
Lipid regulating drugs 1116 (44.0) 1035 (43.4) 81 (52.3) 0.032 0.036
Statins 1026 (40.4) 953 (40.0) 73 (47.1) 0.082 0.139
BP lowering drugs 836 (32.9) 785 (33.0) 51 (32.9) 0.992 0.985
RAS inhibitors 536 (21.1) 509 (21.4) 27 (17.4) 0.245 0.152
Oral anti-diabetic drugs 1776 (70.0) 1667 (70.0) 109 (70.3) 0.923 0.466
Sulphonylureas 727 (28.6) 680 (28.5) 47 (30.3) 0.634 0.571
Use of insulin 774 (30.5) 738 (31.0) 36 (23.2) 0.044 0.858
Psychotropic drugs 183 (7.3) 157 (6.7) 26 (16.9) <0.001 <0.001
Medication adherence score 4.0 (3.0, 4.0) 4.0 (3.0, 4.0) 3.0 (2.0,4.0) <0.001 <0.001
Medication adherence <0.001 <0.001
Low (score 0–1) 175 (7.1) 145 (6.3) 30 (20.0)
Intermediate (score 2–3) 833 (33.9) 771 (33.4) 62 (41.3)
High (score 4) 1450 (59.0) 1392 (60.3) 58 (38.7)
Target achievement
HbA1c <7.0% 1092 (45.0) 1037 (45.6) 55 (36.2) 0.023 0.004
BP <130/80 mmHg 943 (37.3) 882 (37.2) 61 (39.6) 0.546 0.579
LDL <2.6 mmol/L 1145 (48.2) 1066 (47.9) 79 (52.7) 0.259 0.944
Data are presented as mean ± SD, median (interquartile range) or number (%).
*Adjusted for research sites.
Definitions of comorbidities and complications:
1. Coronary heart disease: myocardial infarction, unstable angina, percutaneous coronary intervention, coronary bypass operation.
2. Peripheral vascular disease: lower extremity amputation, absent foot pulses with ankle: brachial index <0.9 and/or lower limb revascularization.
3. Diabetes retinopathy: typical retinal changes including vitrectomy, hemorrhages and exudates.
4. Chronic kidney disease: eGFR <60 mL/min per 1.73 m2; microalbuminuria: urinary ACR ≥2.5–25 mg/mmol [men] or ≥3.5–25 mg/mmol [women]; macroalbuminuria: urinary ACR
>25 mg/mmol.
5. Sensory neuropathy: two of three abnormalities: abnormal sensation in lower limbs, reduced touch sensation to monofilament, reduced vibration sense to graduated tuning fork.
6. Hypertension: systolic BP ≥130 mmHg and/or diastolic BP ≥80 mmHg and/or concurrent use of anti-hypertensive drugs.
7. Dyslipidemia: LDL-C ≥2.6 mmol/L, HDL-C <1.0 mmol/L, triglyceride ≥2.3 mmol/L and/or concurrent use of lipid regulating drugs.
ACR, albumin: creatinine ratio; BP, blood pressure; eGFR, estimated glomerular filtration rate; RAS, renin angiotensin system.
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to the diagnosis of depression in Hong Kong Chinese in
our previous analysis,15 suggesting that more sensitive
tools or lower cut off values will need to be used in
Chinese subjects. Besides, other methodological issues
such as subject characteristics, settings and disease con-
texts will need to be taken into consideration when inter-
preting these results.
In this study, patients residing in Hong Kong had a
higher rate of depression than those recruited in Main-
land China and we speculated that this might be related
to the less favorable socio-economic status, lower educa-
tion level and higher proportions of housewife and
unemployment in the Hong Kong sub-cohort.24 Besides,
Hong Kong has been a British colony for over a century
and its culture and social values are invariably western-
ized. More patients from Hong Kong reported stresses
from work, home and finance and they were more likely
to have family history of mental illnesses (supplementary
Table S1).
Depression and glycemic control
In this study population, depression was associated with
poor glycemic control but without differences in other
metabolic indices, such as blood pressure and lipid.
These results are consistent with reports by others.26,27 In
an earlier meta-analysis of 24 cross-sectional studies
involving 2817 patients, Lustman and colleagues found
that depression was significantly correlated with poor
glycemic control in both type 1 and type 2 diabetes,26
although most of the included studies had small sample
sizes. In the larger scale TRIAD study involving over
8700 subjects, patients with high PHQ-8 scores also had
worse glycemic control than those with low score.20 In a
prospective cohort of over 3700 type 2 diabetic patients
recruited from primary care settings, patients identified
to have minor or major depression at baseline had higher
HbA1c during a 5-year follow-up period, although this
was rendered non-significant after correction for disease
Table 2 Mean number of days in the prior week when patients
adhered to diabetes self-care behaviors stratified by depression*
PHQ-9 < 10 PHQ-9 ≥ 10 P-value
General diet 4.41 ± 0.05 3.97 ± 0.20 0.033
Fruit and vegetables 3.84 ± 0.06 3.51 ± 0.21 0.133
High-fat food consumption 2.41 ± 0.05 2.16 ± 0.19 0.211
SMBG 2.23 ± 0.05 2.32 ± 0.18 0.659
Exercise 3.90 ± 0.06 3.31 ± 0.20 0.005
Foot care 3.97 ± 0.05 3.57 ± 0.17 0.022
Bring along candy 2.60 ± 0.07 2.80 ± 0.25 0.239
*Data are presented as mean ± SE adjusted for study sites, age,
gender and disease duration.
SMBG, Self-monitoring of blood glucose.
Table 3 Stepwise logistic regression for failure to attain HbA1c target(<7.0%)* in Chinese patients with type 2 diabetes (n = 2272)
Model I Model II Model III
OR(95%CI) P OR(95%CI) P OR(95%CI) P
PHQ-9 score ≥10 1.56 (1.06–2.30) 0.023 1.56 (1.05–2.32) 0.028 1.48 (0.99–2.21) 0.058
Demographic characteristics
Age, years 0.96 (0.95–0.97) <0.001 0.96 (0.95–0.97) <0.001 0.96 (0.95–0.97) <0.001
Men 0.87 (0.71–1.06) 0.165 0.85 (0.69–1.05) 0.123 0.84 (0.68–1.04) 0.104
Duration of diabetes, years 1.09 (1.08–1.11) <0.001 1.09 (1.07–1.11) <0.001 1.09 (1.07–1.11) <0.001
Current smoker 1.65 (1.26–2.15) <0.001 1.59 (1.21–2.09) 0.001 1.53 (1.16–2.02) 0.003
Low education (<6 years) 1.75 (1.33–2.31) <0.001 1.64 (1.24–2.18) 0.001 1.58 (1.19–2.11) 0.002
Clinical characteristics†
Body mass index, kg/m2 1.10 (1.07–1.13) <0.001 1.10 (1.07–1.13) <0.001
Coronary heart disease 1.17 (0.83–1.66) 0.370 1.16 (0.82–1.64) 0.411
Sensory neuropathy 1.22 (0.92–1.63) 0.169 1.21 (0.91–1.61) 0.196
Use of insulin 2.72 (2.17–3.41) <0.001 2.79 (2.22–3.50) <0.001
Self-care and medication adherence
SDSCA general diet 0.95 (0.91–0.99) 0.007
SDSCA exercise 1.01 (0.97–1.05) 0.679
Medication adherence score‡ 0.90 (0.82–1.00) 0.043
PHQ-9, Patient Health Questionnaire-9; SDSCA, Summary of Diabetes Self-care Activities, score ranges from 0 to 7, with higher score indicating
better adherence to recommended self-care regimen.
*HbA1c ≥7.0% was used as the reference dependent outcome. Clinical characteristics and self-care behaviors significant at P < 0.1 level were
sequentially entered into the model. All models were adjusted for study sites.
†Waist circumference was not adjusted for due to collinearity with body mass index.
‡Medication adherence score (range: 0–4) was used as a continuous variable in the model. Higher score indicates better medication adherence.
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duration, history of cardiovascular disease, hypertension
and anti-diabetic treatment.27
Depression and adherence
Other researchers have suggested that suboptimal glyce-
mic control in co-morbid depression might be partly
explained by non-adherence with self-care and medica-
tions.28 In a meta-analysis of 47 cohort studies, depres-
sion was associated with poor self-care, medication
non-adherence and frequent defaults.29 Congruent to
these observations, we also found that the group with
probable depression were less likely to adhere to general
diet and physical exercise, and had higher rates of medi-
cation non-adherence. The fact that the association of
depression with failure to attain HbA1c target was ren-
dered non-significant after adjustment for SDSCA diet
and exercise subscale score as well as medication adher-
ence score further suggested that poor glycemic control
in patients with depression might be mediated by subop-
timal adherence to self-care and medication. Because of
this, the complex anti-diabetic regimen and polyphar-
macy, often applied to patients with a long disease dura-
tion and with multiple risk factors, can be associated
with unwanted side-effects including hypoglycemia and
weight gain.17,30 In our cohort, one-fifth of patients with
probable depression were treated with insulin, which
might be associated with social stigma and met with
resistance due to pain, inconvenience and interference
with daily life.31
Hypoglycemia and depression
Apart from high HbA1c, patients with probable depres-
sion were twice more likely to report hypoglycemia than
the non-depressed group, even after adjustment for
potential confounders, including disease duration, renal
function, use of insulin and sulphonylurea. The indepen-
dent association of depression on symptomatic and
severe hypoglycemia had been well reported. In a pro-
spective study of 4117 adults with diabetes, depression
was associated with a hazard ratio of 1.42 for hospital-
ization for hypoglycemia.32 In the Study to Help Improve
Early evaluation and management of risk factors
Leading to Diabetes (SHIELD) survey of 2718 patients
with type 2 diabetes, those reporting hypoglycemia
during the previous 1 year had higher PHQ-9 scores than
those without hypoglycemia.33
In most clinical trials conducted in controlled settings,
hypoglycemia was often associated with tight glycemic
control.34 In our study, we also found this association
although we also noted high glycemic variability in
patients with depression, which might be due to multiple
reasons, such as suboptimal treatment adherence with
sporadic intake of medications, erratic meal plan, insuf-
ficient preventative measures for hypoglycemia and poor
motivation to improve self-management.35 Besides, fear
of hypoglycemia might also lead to unwillingness to
intensify treatment or over-correction for hypoglycemia.
From a biological standpoint, high cortisol levels and
dysregulation of the autonomic nervous system might
also lead to fluctuations in glycemic control.36 In support
of this notion, both hypoglycemia and glycemic variabil-
ity were independent predictors for mortality and
cardiovascular-renal events in Chinese type 2 diabetic
patients.37,38
Study limitations
Several limitations of this study need to be acknowl-
edged. First, all our patients were recruited from
hospital-based clinics and thus might not be representa-
tive of the general diabetic population in China. That
said, in China including HongKong, primary health care
for managing chronic conditions like diabetes still
remains relatively under-developed and many diabetic
patients still receive their care in hospital-based clinics,
irrespective of disease severity. On the other hand, we
only involved clinics from metropolitan cities and thus
patients living in rural areas were not represented.
Table 4 Logistic regression for self-reported hypoglycemia in
Chinese patients with type 2 diabetes (n = 2159)*
OR (95%CI) P-value
PHQ-9 ≥ 10 2.62 (1.74–3.96) <0.001
Age (years) 0.98 (0.97–1.00) 0.017
Men 1.10 (0.85–1.43) 0.474
Disease duration (years) 1.04 (1.02–1.07) <0.001
Low education (<6 years) 0.79 (0.53–1.17) 0.238
Regular alcohol use 1.28 (0.83–1.96) 0.267
History of diabetic retinopathy 0.89 (0.61–1.29) 0.529
History of sensory neuropathy 1.35 (0.96–1.88) 0.084
History of cardiovascular disease 1.16 (0.85–1.60) 0.351
HbA1c (%) 0.85 (0.78–0.93) <0.001
eGFR (mL/min per 1.73 m2) 1.00 (1.00–1.01) 0.711
Use of insulin 2.28 (1.69–3.08) <0.001
Use of sulphonylurea 1.72 (1.31–2.24) <0.001
SDSCA general diet 1.00 (0.95–1.05) 0.911
SDSCA exercise 1.00 (0.95–1.05) 0.966
Medication adherence score† 1.01 (0.90–1.15) 0.815
*The model was adjusted for study sites. Any self-reported hypogly-
cemia during the previous 3 months was used as the reference.
†Medication adherence score (range: 0–4) was used as a continue
variable in the model. Higher score indicates better medication
adherence.
eGFR, estimated glomerular filtration rate; SDSCA, Summary of Dia-
betes Self-care Activities. Score ranges from 0 to 7, with higher score
indicating better adherence to recommended self-care regimen.
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Second, our JADE database did not have data on
marital status and income, which might have prognostic
significance for depression.39 Third, patients with prob-
able depression did not receive formal psychiatric exami-
nation to confirm a diagnosis of major depression.
However we have chosen to take a high score of the
PHQ-9(≥10) to indicate depression, which is higher than
the optimal cutoff score (≥7) previously validated in the
same group of Hong Kong patients. Lastly, due to the
cross-sectional nature of our study, we were not able to
establish any definitive causal relationships.
Conclusions
In this observational study, depression was associated
with both hyperglycemia and hypoglycemia accompa-
nied by suboptimal self-care and treatment adherence. In
diabetic patients with variable glycemic control, physi-
cians should consider the possibility of underlying
depression and adopt a more holistic approach to
manage depression and emotional distress which might
improve both medication adherence and self-care. The
fact that less than one fifth of patients with depression
were receiving treatment for it underlines the importance
of this recommendation.
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